Novel once-weekly injectable VMAT2 inhibitor targets underserved patients with serious adherence and access challenges – - Potential expansion into Huntington’s chorea – an underserved indication with ...

Tremors, stiffness, and slowed movement are classic signs of Parkinson's disease. Learn more about the signs and symptoms of Parkinson's disease.

A team led by UT Southwestern Medical Center researchers has uncovered the atomic structure of a protein complex pivotal to ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) develops therapies targeting neurological, neuroendocrine, and neuropsychiatric ...

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is one of the best strong buy healthcare stocks to buy now. On July 22, Morgan ...

Medically reviewed by Nicholas R. Metrus, MD Tardive dyskinesia and dystonia are both neurological disorders that can affect ...

A team led by UT Southwestern Medical Center researchers has uncovered the atomic structure of a protein complex pivotal to ...

In the effort to deport millions of law-abiding and productive undocumented immigrants, the deployment of heuristic ...

Q1 2025 delivered first positive adjusted EBITDA result since 2021 and guided to a break-even adjusted EBITDA result for ...

S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell therapy for Parkinson's disease. The data demonstrate a favorable safety and ...

A new study published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry found that cannabidiol ...

Tiny fat bubbles carrying gene therapy have successfully repaired DNA in the lungs and liver of animals with alpha-1 antitrypsin deficiency—a promising leap toward treating humans with this rare ...